Hospira launches generic Gemzar

LAKE FOREST, Ill. Generic injectable drug maker Hospira has launched a version of a chemotherapy drug, the company said Monday.

Hospira announced the launch of gemcitabine hydrochloride in 2-g vials, a generic version of Eli Lilly’s Gemzar.

Gemzar had sales of nearly $750 million in 2009, according to Hospira.